Amikacin pharmacokinetics in adults: A variability that question the dose calculation based on weight;Pharmacocinétique de l'amikacine chez l'adulte : une hétérogénéité qui remet en cause le calcul de la dose basé sur le poids

Therapie

Volumn 64, Issue 1, 2009, Pages 47-53

  Bourguignon, Laurent ^a,b,c   Goutelle, Sylvain ^a,b,c   Gérard, Cécile ^c   Guillermet, Anne ^c   De Saint Martin, Julie Burdin ^c   Maire, Pascal ^a,b,c   Ducher, Michel ^b,c  

^a UNIVERSITÉ LYON 1   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c ADCAPT   (France)

Author keywords

Amikacin; Drug dosage calculations; Pharmaco kinetics

Indexed keywords

AMIKACIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEMOGRAPHY; DOSE CALCULATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 67650334424     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie/2009009     Document Type: Article

References (23)

1. Evans WE, Schentag JJ, Jusko WJ. Applied Pharmacokinetics: rinciples of therapeutic Drug monitoring, 3 ed. Applied Therapeutics, Inc. 1992
2. Garraffo R, Drugeon HB, Dellamonica P, et al. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharma-cokinetics and bactericidal activity. Antimicrob Agents Chemother 1990; 34: 614-21
3. Pivot-Dumarest C, Deweerdt C, Troncy J, et al. Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in oncohematology. Pathol Biol (Paris) 1996; 44: 299-305
4. Zaske DE, Strate RG, Kohls PR. Amikacin pharmacokinetics: wide interpatient variation in 98 patients. J Clin Pharmacol 1991; 31: 158-63
5. Zaske DE. Aminoglycosides. In: Applied therapeutics editor. Applied Pharmacokinetics, 3rnd éd. Vancouver, 1992; 14-1, 14-47
6. Ritschel WA. Handbook of basic pharmacokinetics, 3 ed. Drug Intelligence Publications, Inc. 1986
7. Bauer LA, Blouin RA, Griffen WO, et al. Amikacin pharmacokinetics in morbidly obese patients. Am J Hosp Pharm 1980; 37: 519-22
8. Ducher M, Maire P, Cerutti C, et al. Renal elimination of amikacin and the aging process. Clin Pharmacokinet 2001; 40: 947-53
9. Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-71
10. Jelliffe RW, Jelliffe SM. Estimation of creatinine clearance from changing serum-creatinine levels. Lancet 1971; 2: 710
11. Jelliffe R. Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen. Am J Nephrol 2002; 22: 320-4
12. Jain AK, Murty MN, Flynn PJ. Data clustering: a review. ACM Computing Surveys 1999; 31: 264-323
13. th Annual Meeting of the Population Approach Group in Europe, 2001, Basel, Switzerland
14. Bustad A, Terziivanov D, Leary R, et al. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin Pharmacokinet 2006; 45: 365-83
15. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19: 716-23
16. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503-12
17. Bourgoin A, Martin C. Bases pharmacocinétiques et pharmacodynamiques de l'antibiothérapie probabiliste. Ann Fr Anesth Réanim 2004; 23: 626-30 18. Belfayol L, Talon P, Eveillard M, et al. Pharmacokinetics of once-daily amikacin in pediatric patients. Clin Microbiol Infect 1996; 2: 186-91
18. Maire P. Amikacine chez le sujet âgé : aide à la décision. La Lettre de l'Infectiologue 1995; Hors série:31-33
19. Tod M, Lortholary O, Seytre D, et al. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults. Antimicrob Agents Chemother 1998; 42: 849-56
20. Bressolle F, Gouby A, Martinez JM, et al. Population pharmacokinetics of amikacin in criticalli ill patients. Antimicrob Agents Chemother 1996; 40: 1682-89
21. Romano S, Fdez de Gatta MM, Calvo MV, et al. Population pharmacokinetics of amikacine in patient with haematological malignancies. Journal of Antimicrobial Chemotherapy 1999; 44: 235-42
22. Mallet A, Mentre F, Gilles J, et al. Handling covariates in population pharmacokinetics, with an application to gentamicin. Biomed Meas Infor Contr 1988; 2: 138-46
23. Semmar N, Bruguerolle B, Boullu-Ciocca S, et al. Cluster analysis: an alternative method for covariate selection in population pharmacokinetic modeling. J Pharmacokinet Pharmacodyn 2005; 32: 333-58